Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00762515 · ClinicalTrials.gov registry record · Phase 3

Clinical Study to Evaluate the Treatment of Gingivitis of Two Toothpastes

A Phase 3 study of Dental Plaque, sponsored by Colgate Palmolive.

Completed
Registry status
Phase 3
Development phase
44
Enrollment target
1
Study location

NCT00762515: Completed Phase 3 study of Dental Plaque, sponsored by Colgate Palmolive.

NCT00762515 is a Phase 3 study of Dental Plaque that has completed, run by Colgate Palmolive. The registered enrollment target is 44 participants, below the 620-participant average among 10 other Dental Plaque trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00762515, a Phase 3 study of Dental Plaque, has completed, sponsored by Colgate Palmolive.

COMPLETED
Registry status
Phase 3
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

The objective is to compare two commerical oral products for the treatment of gingivitis.

Primary Outcome

Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth. Total Plaque score=sum of all scores divided by the number of sites (teeth) scored.

Conditions Studied

Interventions

  • DRUG Fluoride
  • DRUG Triclosan

Study Locations (1)

Kentucky

  • University of Louisville, School of Dentistry - Louisville

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2008-02
Est. Completion 2008-08
Phase Phase 3
Colgate Palmolive

51 total trials

What the finished NCT00762515 record still lists

NCT00762515 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 620-participant average among 10 other Dental Plaque trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Dental Plaque appearing as the primary indexed condition, and to 2 interventions - of which Fluoride is the first listed.

NCT00762515 reports a single indexed study location in Kentucky.

Frequently Asked Questions

What is clinical trial NCT00762515 about?

NCT00762515 is a clinical study titled "Clinical Study to Evaluate the Treatment of Gingivitis of Two Toothpastes". The objective is to compare two commerical oral products for the treatment of gingivitis.

What is the current status of trial NCT00762515?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 44 participants. The study started on 2008-02. Estimated completion is 2008-08.

What conditions does trial NCT00762515 study?

This clinical trial studies the following conditions: Dental Plaque.

What interventions are being tested in trial NCT00762515?

The interventions under investigation include: Fluoride (DRUG), Triclosan (DRUG).

Who is sponsoring clinical trial NCT00762515?

This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00762515 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dental Plaque

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00762515's enrollment target sits among peer trials

44 8th of 10 higher than 3 of 10 other Dental Plaque trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dental Plaque trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00762515, the US trial registry maintained by the National Library of Medicine. NCT00762515 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.